资讯
58 分钟
Stockhead on MSNHealth Check: Cancer drug developers drive further positive Car-T results
Two of the leading developers of Car-T immuno-oncology drugs, Imugene and Chimeric have unveiled further positive trial ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果